# Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

> **NCT00799435** · PHASE4 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 2 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Heart Failure, Diastolic

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT00799435
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Inability to recruit adequate Sample Size who met the entry criteria
- **Last updated:** 2020-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799435, "Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00799435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*